TWST

Twist Bioscience Corp

Add to Watchlist

Advanced Chart

25.640

+0.64(2.560%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

25.950

Open

25.400

VWAP

25.60

Vol

1.97M

Mkt Cap

1.55B

Low

24.8779

Amount

50.42M

EV/EBITDA(TTM)

Total Shares

58.23M

1.26B

EV/OCF(TTM)

P/S(TTM)

4.12

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

97.41M

+14.99%

101.10M

+13.97%

106.97M

+15.28%

Estimates Revision

The market is revising Upward the revenue expectations for Twist Bioscience Corporation (TWST) for FY2025, with the revenue forecasts being adjusted by 0.06% over the past three months. During the same period, the stock price has changed by -16.81%.

Revenue Estimates for FY2025

Revise Upward

+0.06%

In Past 3 Month

Stock Price

Go Down

-16.81%

In Past 3 Month

8 Analyst Rating

84.98% Upside

Wall Street analysts forecast TWST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TWST is 47.43 USD with a low forecast of 33.00 USD and a high forecast of 62.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Buy

1 Hold

1 Sell

Moderate Buy

84.98% Upside

Current: 25.640

Low

33.00

Averages

47.43

High

62.00

84.98% Upside

Current: 25.640

Low

33.00

Averages

47.43

High

62.00

Evercore ISI

Outperform

downgrade

$50 -> $46

2025-08-04

New

Reason

Evercore ISI

Price Target

$50 -> $46

2025-08-04

New

downgrade

Outperform

Reason

Evercore ISI lowered the firm's price target on Twist Bioscience to $46 from $50 and keeps an Outperform rating on the shares. The firm updated the company's model post the fiscal Q3 report. It views the quarter as "decent" with solid gross margins. Twist has solid momentum entering fiscal 2026, the analyst tells investors in a research note.

TD Cowen

Brendan Smith

Buy

downgrade

$58 -> $36

2025-08-04

New

Reason

TD Cowen

Brendan Smith

Price Target

$58 -> $36

2025-08-04

New

downgrade

Buy

Reason

TD Cowen analyst Brendan Smith lowered the firm's price target on Twist Bioscience to $36 from $58 and keeps a Buy rating on the shares. The stock has been under pressure following Q3 revenue that was in line with guidance and the narrowing of FY25 guidance as investor hoped for "a clean beat/raise." The firm, which is trimming near-term estimstes for SynBio, largely offset by consistent NGS growth into next year, now assigns a multiple closer to peer trading multiples to reflect updated growth assumptions.

Barclays

Luke Sergott

Buy

Maintains

$58 → $45

2025-04-10

Reason

Barclays

Luke Sergott

Price Target

$58 → $45

2025-04-10

Maintains

Buy

Reason

JP Morgan

Rachel Vatnsdal

Sell

Maintains

$35 → $40

2025-02-04

Reason

JP Morgan

Rachel Vatnsdal

Price Target

$35 → $40

2025-02-04

Maintains

Sell

Reason

Baird

Catherine Ramsey

Buy

Maintains

$48 → $54

2025-02-04

Reason

Baird

Catherine Ramsey

Price Target

$48 → $54

2025-02-04

Maintains

Buy

Reason

Scotiabank

Sung Ji Nam

Buy

Maintains

$54 → $62

2025-02-04

Reason

Scotiabank

Sung Ji Nam

Price Target

$54 → $62

2025-02-04

Maintains

Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Twist Bioscience Corp (TWST.O) is -17.01, compared to its 5-year average forward P/E of -18.28. For a more detailed relative valuation and DCF analysis to assess Twist Bioscience Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-18.28

Current PE

-17.01

Overvalued PE

-5.59

Undervalued PE

-30.97

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-17.99

Current EV/EBITDA

-18.42

Overvalued EV/EBITDA

-4.88

Undervalued EV/EBITDA

-31.09

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

15.66

Current PS

3.62

Overvalued PS

31.38

Undervalued PS

-0.07

Financials

Annual

Quarterly

FY2025Q3

YoY :

+17.91%

96.06M

Total Revenue

FY2025Q3

YoY :

-31.53%

-30.12M

Operating Profit

FY2025Q3

YoY :

-123.83%

20.39M

Net Income after Tax

FY2025Q3

YoY :

-122.45%

0.33

EPS - Diluted

FY2025Q3

YoY :

+43.88%

-10.57M

Free Cash Flow

FY2025Q3

YoY :

+23.33%

53.40

Gross Profit Margin - %

FY2025Q3

YoY :

-25.29%

-18.97

FCF Margin - %

FY2025Q3

YoY :

-120.21%

21.23

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

674.4K

USD

3-6

Months

745.6K

USD

6-9

Months

1.8M

USD

0-12

Months

3.2M

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds areSelling! The selling amount has increased 634.68% over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

128.8K

Volume

6-9

Months

17.5K

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

1.1M

Volume

Months

6-9

2.8M

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

674.4K

USD

3-6

Months

745.6K

USD

6-9

Months

1.8M

USD

0-12

Months

3.2M

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

TWST News & Events

Events Timeline

2025-08-04 (ET)

2025-08-04

12:02:22

Twist Bioscience falls -16.4%

2025-08-04

07:32:54

Twist Bioscience narrows FY25 revenue view to $374M-$376M from $372M-$379M

2025-08-04

07:29:52

Twist Bioscience sees Q4 revenue $96M-$98M, consensus $98.97M

News

5.0

08-07TipRanks

Cathie Wood ‘Buys the Dip’ in AMD Stock after Q2 Results, Cuts Roblox and Palantir (PLTR) Stakes

5.0

08-06TipRanks

CRSP, TWST: Cathie Wood Bets Millions on Biotech, Continues Dumping Roblox

5.0

08-06Benzinga

Cathie Wood's Ark Dumps Block Stock Worth $4.8 Million As Bitcoin-Heavy Company Preps Q2 Results

People Also Watch

LUNR

Intuitive Machines Inc

Laureate Education Inc

Enova International Inc

American States Water Co

Chesapeake Utilities Corp

FAQ

What is Twist Bioscience Corp (TWST) stock price today?

The current price of TWST is 25.64 USD — it has increased 2.56 % in the last trading day.

TWST

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

TWST News & Events

Events Timeline

News

People Also Watch

FAQ

What is Twist Bioscience Corp (TWST) stock price today?

What is Twist Bioscience Corp (TWST)'s business?

What is the price predicton of TWST Stock?

What is Twist Bioscience Corp (TWST)'s revenue for the last quarter?

What is Twist Bioscience Corp (TWST)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Twist Bioscience Corp (TWST)'s fundamentals?

How many employees does Twist Bioscience Corp (TWST). have?

What is Twist Bioscience Corp (TWST) market cap?